Unraveling the complexity of cell cycle effects of anticancer drugs in cell populations

被引:0
|
作者
Ubezio, P [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
关键词
mathematical models of the cell cycle; cell proliferation; anticancer drugs; complexity; flow cytometry;
D O I
暂无
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
Cell cycle perturbations occur after treatment with all anticancer drugs. The perturbations are usually classified as cytostatic (cell cycle arrest) or cytotoxic (cell killing). Our approach for analysis of cell cycle perturbations in vitro was to consider all the data provided by different experimental tests and interpret them through a mathematical formulation of the problem. The model adopted for data analysis and interpretation is the result of merging two models, one for the cell cycle and the other for the drug effects. The first exploits the results of the theory of age-structured cell population dynamics while the second is based on distinct parameters ("effect descriptors") directly linked to cell cycle arrest, damage repair or cell death in G(1) and G(2)M and to inhibition of DNA synthesis and death in S. The set of values of the effect descriptors which are coherent with all experimental data are used to estimate the cytostatic and cytotoxic effects separately. Applying the procedure to data from in vitro experiments, we found complex but biologically consistent patterns of time and dose dependence for each cell cycle effect descriptor, opening the way for a link to the parallel changes in the molecular pathways associated with each effect.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 50 条
  • [1] ESTIMATION AND PREDICTION OF CELL-CYCLE EFFECTS OF ANTICANCER DRUGS
    KIMMEL, M
    TRAGANOS, F
    CELL AND TISSUE KINETICS, 1987, 20 (06): : 634 - 634
  • [2] ESTIMATION AND PREDICTION OF CELL-CYCLE SPECIFIC EFFECTS OF ANTICANCER DRUGS
    KIMMEL, M
    TRAGANOS, F
    MATHEMATICAL BIOSCIENCES, 1986, 80 (02) : 187 - 208
  • [3] Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development
    Darwiche, Nadine
    El-Banna, Sara
    Gali-Muhtasib, Hala
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (03) : 361 - 379
  • [4] Anticancer therapy and the cell cycle
    Smith, PJ
    BRITISH JOURNAL OF CANCER, 1996, 74 : SP23 - SP23
  • [5] THE LINKING OF ANTICANCER DRUGS, CELL-CYCLE BLOCKS, AND DIFFERENTIATION - IMPLICATIONS IN THE SEARCH FOR ANTINEOPLASTIC DRUGS
    DINNEN, RD
    EBISUZAKI, K
    LEUKEMIA RESEARCH, 1992, 16 (05) : 491 - 495
  • [6] Interpreting cell cycle effects of drugs: the case of melphalan
    Monica Lupi
    Paolo Cappella
    Giada Matera
    Claudia Natoli
    Paolo Ubezio
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 443 - 457
  • [7] MODULATING EFFECTS OF DRUGS ON CELL-CYCLE KINETICS
    RONOT, X
    ADOLPHE, M
    BIOLOGY OF THE CELL, 1986, 58 (02) : 139 - 146
  • [8] Interpreting cell cycle effects of drugs: the case of melphalan
    Lupi, M
    Cappella, P
    Matera, G
    Natoli, C
    Ubezio, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (04) : 443 - 457
  • [9] New anticancer therapeutic targets in the cell cycle and cell cycle checkpoints
    Pommier, Y
    Kohn, KW
    M S-MEDECINE SCIENCES, 2003, 19 (02): : 173 - 186
  • [10] Measuring the complexity of cell cycle arrest and killing of drugs: Kinetics of phase-specific effects induced by Taxol
    Sena, G
    Onado, C
    Cappella, P
    Montalenti, F
    Ubezio, P
    CYTOMETRY, 1999, 37 (02): : 113 - 124